clinicaltrials.gov ghk-cu What Is GHK-Cu? Discovery & Research GHK-Cu Research Peptide Australia |

Glad to hear that this got resolved, Jill

However, study results for some are sparse, or have not been published in scientific journals

Key characteristics of Ipamorelin include: Selective action on growth hormone release Short half-life of approximately 2 hours Clean safety profile with minimal side effects How these peptides work together The synergy between CJC-1295 and Ipamorelin creates a powerful combination that maximizes growth hormone production through complementary mechanisms: When prescribed together, these peptides typically produce a 3-5 fold increase in growth hormone release compared to using either compound alone

It is studied in preclinical research for its role in metabolic regulation and NAD+ biology